Additionally, by reducing the reabsorption of glucose and sodium in the renal proximal tubules, SGLT-2 inhibitors reduce the kidney’s metabolic load, helping to slow kidney damage caused by excessive glucose and sodium reabsorption. Here, SLC5A2 is linked to Nephropathy.